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INTRODUCTiON 
GENERAL : 
Alpha-2-macroglobul in (a2'^) is one of the major plasma 
proteinase inhibitors found in human blood ' (Starkey and 
Barrett, 1982) and that of other mammals (Enghild et al., 
1990). The human a2M is a tetrameric glycoprotein of 720 
KDa, that interferes with the action of proteinases from all 
the four major classes (Barrett and Starkey, 1973). The 
inhibitor is composed of four equivalent polypeptides of 180 
KDa that are associated into pairs by disulfide bonds and 
whole molecules by strong non-covalent interactions- The 0(2^ 
differs from other active site directed proteinase 
inhibitors (Travis and Salvesen, 1983) in that the active 
site of the enzyme in the a2M-enzyme complex retains its 
catalytic potential for small molecular weight substrates, 
while the hydrolysis of protein substrates appears to be 
sterically hindered. 
The term a2-macroglobulin was coined by Schultze et 
al. (1955) to describe the electrophoretic mobility and 
large molecular weight of the protein. a2^ was first 
isolated as the thermocoagulable a2~glycoprotein from Cohn's 
fraction III-O by Brown et al. (1954). Schonenberger et 
al. (1958) calculated its molecular weight to be of 820-950 
KDa,by sedimentation and diffusion coefficient measurements. 
Alpha-2-macroglobulin was first recognised as proteinase 
inhibitor when Schultze et al . (1963) isolated the «2-
plasmin inhibitor and established its identity with a2'*'' 
The mechanism of binding of proteinase to <X2^ is 
undoubtedly unique and fascinating. The "bait region" 
located between residues 666-706 (Sottrup-Jensen et al., 
1989) and reactive internal thiolester, formed from the side 
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chains of Cys and Glx in each subunit (Sottrup-Jensen 
et al., 1980; Howard, 1981), constitute two key elements in 
the proteinase binding mechanism of <X2^- The bait region 
contains specific sites, susceptible to proteolytic cleavage 
by almost all proteinases (Sottrup-Jensen et al., 1989). 
Following cleavage, the tetrameric a2f^  undergoes extensive 
conformational changes resulting in the entrapment of the 
proteinase (Van Leuven, 1982). As a result of this change, 
the internal thiolester becomes activated and this forms 
short lived "nascent" or "activated" a2M which reacts 
rapidly with the available amino group on the surface of the 
proteinase (Sottrup-Jensen et al., 1980; Salvesen et al., 
1981). This results in covalent binding of prot-einase 
through one or more €;—lysyl (Proteinase )-r-glutamyl (a2M) 
crosslinks (Sottrup-Jensen et al., 1981; Sottrup-Jensen, and 
Hansen, 1982). Formation of covalent bond between the 02M 
and the proteinase is however, not essential for blocking of 
the proteinase action (Salvesen and Barrett, 1980). Physical 
entrapment of proteinase in <X2^t also masks the antigenicity 
of the entrapped enzyme (Haverback et al., 1962). 
The conformational change in 1x2^ causes the exposure of 
the receptor recognition site, which facilitates the binding 
of a2M~proteinase complex to cell surface receptors and 
allows rapid clearance of the inhibitor from the circulation 
(Van Leuven et al., 1979; Imber et al., 1981). 
The CX2M provides a potential system for controlling the 
activity of proteinase. Besides controlling proteinase 
activity, a2M is known to be the major binding protein for 
zinc (Parisi and Vallee, 1970; Prasad and Oberleas, 1970). 
It is also reported that a2^ binds to some cytokines such as 
Tumor necrosis factor (Wollenberg et al., 1991), 
Transforming Growth factor G-1 (La Marre et al., 1991) and 
clears them from circulation by specific receptor mediated 
endocytosis akin to a2M proteinase complex clearance (La 
Marre et al., 1991). It is believed that clearance of 02^-
enzyme complex may be of greater physiological importance 
than simple modification of enzyme activity (Starkey and 
Barrett, 1971). 
02^ 1 has been isolated from invertebrates, fish, 
reptiles, birds and many mammalian species (Enghild et al., 
1990) and their structures were found to be highly conserved 
throughout the evolution. The family comprises of proteinase 
inhibitors such as human a2M and complement factors C3, C4 
and C5. Evolutionary relationship between these proteins 
became obvious when it was found that all members of the 
family were synthesized as 185 KDa-precursor and this 
precursor from different members were found to be remarkably 
conserved at several stretches of the sequence (Sottrup-
Jensen et al., 1985). The relationship was further 
strengthened by the presence of an internal fl-cystienyl-F-
glutamyl thiolester in C3, C4 and a2M (Swenson and Howard, 
1979; Tack et al., 1980). Except for the complement members, 
the members of alpha-macroglobulin family have been 
characterized on the basis of proteinase inhibition (Enghild 
et al., 1990). 
flOLECULflR STRUCTURE : 
<X2^ is a 720-725 KDa tetrameric glycoprotein (Hall and 
Roberts, 1978; Jones et al., 1972), consisting of four 185 
KDa sub-units (Harpel, 1973; Barrett et al., 1979) which are 
chemically identical (Swenson and Howard, 1979). Disulfide 
bonds bridge subunits into pairs that have molecular weight 
of approximately 360 KDa (Harpel, 1973). Strong noncovalent 
forces (Hall and Roberts, 1978) including hydrophobic 
interactions (Sjoeberg et al., 1992) are responsible for the 
association of pairs into whole molecules. The four 
identical subunits of the native a2M are arranged to form 
two distinct proteinase binding sites (Swenson and Howard, 
1979; Pochon et al., 1978). The proteinase binding sites 
are equivalent, non-interacting (Pochon and Beith, 1982; 
Gonias and Pizzo, 1983), adjacent (Pochon et al., 1981) 
and located on t.'ne protein surface (Bieth et al., 1981). 
The binding stoichiometry of 02M "for most of the 
proteolytic enzy.-ne is 2:1, (Van Leuven, 1982; Gonias and 
Pizzo, 1983). Inability of o(2M molecule to bind 2 molecules 
of large proteinase such as plasmin can be explained by 
steric hindrance caused by the protrusion of one proteinase 
into the second binding site (Pochon et al., 1981). 
a) The Bait Region :- The human a2^ subunit, as shown in 
Fig. 1, contains an exposed stretch known as "bait 
region" constituted by residues 666-706 (Sottrup-Jensen 
et al., 1989), which is uniquely sensitive to cleavage 
by proteinase as it offers susceptible peptide linkages 
for almost all types of proteinases (Hall et al., 1981; 
Sottrup-Jensen et al., 1981a). This stretch is free of 
protecting carbohydrate moieties and restricting 
disulfide bonds (Salvesen and Barrett, 1980), making 
this region highly accessible for endopeptidase attack. 
Bait region cleavage by the proteinase triggers a 
conformational change in a2M resulting in the 
entrapment of the proteinase. This conformational 
change may be caused by transfer of newly generated 
amino or carboxyl terminal charges in the cleaved bait 
region to specific internal position or because of 
release of strain (Sottrup-Jensen et al., 1989). 
b) The Reactive Internal fl-Cysteinyl—r-Glutamyl Thiol-
ester :- The conformational change initiated by the 
bait region cleavage leads to activation of internal 
949 952 thiolester formed from Cys and Glx in each 02M 
Figure 1 The structure of 0(2M subunit. 
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5ubunit (Sottrup-Jensen et al. , 1980; Sottrup-Jensen et 
al., 1984). The short lived nascent state could be 
considered as "pseudo-enzymatic site", turning over 
once and for all to form covalent crosslink with the 
activating proteinase through C-lysyl (Proteinase)-F-
glutamyl (0(2^ ) bond (Sottrup-Jensen, 1987) (Fig.2). 
The thiolester group of the non-proteolysed a2^ is also 
susceptible to the nucleophilic attack by small amines 
leading to their covalent incorporation (Barrett et 
al., 1979)..The rate of reaction with amines rapidly 
falls off as the chain length of amines is increased, 
suggesting that the thiolester bond is sterically well 
protected in native <X2f^ (Robert, 1986). Heat or 
alkaline pH cleaves a peptide bond adjacent to the 
glutamic acid residue apparently preceeded by an 
internal nucleophilic attack by the amide group of the 
peptide bond resulting in formation of an internal 
pyroglutamyl residue and cleavage of the peptide bond 
results in fragmentation of the subunit (Salvesen et 
al., 1981; Howard, 1981) (Fig. 3 ) . 
c) The Receptor Binding Domain :- As a result of the 
conformational change occuring in a2M due to cleavage 
of the thiolesters, previously concealed receptor 
recognition sites becomes exposed on the inhibitor 
molecule. This site is recognised by the receptor 
Figure Z Formation of covalent bonds between a2M and 
proteinase by way of the thiolester bond loop. 
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present on the surface of a variety of cells including 
fibroblast, macrophages and hepatocyte <Van Leuven et 
al., 1979), causing rapid clearance and degradation of 
a2M-proteinase complexes (Imber and Pizzo, 1981). This 
neo-antigenic site was mapped to within about 20 KDa 
from-CDOH terminal of a2M subunits (Van Leuven et al., 
1986). 
d) Transglutaminase Crosslinkinq Site :- Adjacent to the 
bait region, there is a transglutaminase crosslinking 
site. The site is involved in the clustering of 
a2'^ proteinase complex bound on receptor bearing cells 
and its endocytosis into a variety of cells (Mortensen 
et al . , 1981). Its involvement in intracellular 
receptor-recycling has also been suggested (Van Leuven 
et al., 1980; Van Leuven et al . , 1981). 
e) The Carbohydrate Chains :- Alpha-2-macroglobulin is a 
glycoprotein with a total carbohydrate content of 9.43'/. 
of the total dry weight of the molecule (Dunn and 
Spiro, 1967). Detailed analysis of purified 
glycopeptide obtained from pronase digests showed that 
a2M contained 31 carbohydrate chains per molecule with 
an average of 3 residuce of mannose, 2 of galactose, 
1.5 of sialic acid, 4 of fructose and 4.7 of N-
acetyIglucosamine (Dunn and Spiro, 1967). The 
carbohydrate units are attached to the protein by 
Figure 3 The structure of the thiolester bond loop in ct.^^ 
and reaction products upon reaction with amines 
(Upper reactions) and during heat/alkaline 
cleavage of the subunit chains (Lower reactions). 
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glycDsylamine linkage to asparagyl residues. Two points 
of attachment of these carbohydrate moieties have been 
identified, one in thiolester loop region and other in 
20 KDa receptor binding domain. 
flECHflNISM OF INTERACTION WITH PROTEINASE : 
The current working hypothesis for the inhibition of 
proteinase which accounts for all known features associated 
with a2^ inhibition was proposed by Barrett and Starkey 
(1973). The "trap" hypothesis of Barrett and Starkey (1973) 
proposes that binding of proteinase is initiated by the 
proteolytic attack on the bait region of the <X2^^ which 
induces -a conformational change leading to irreversible 
entrapment of the enzyme within the inhibitor molecule. The 
entrapment prevents expression of proteolytic activity by 
sterically hindering the access of large molecular weight 
substrates. The entrapped proteinase becomes insensitive to 
large molecular weight substrates or inhibitors but remains 
accessible to low molecular weight substrates and inhibitors 
(Haverback et al., 1962; Ganrot, 1966; Karic and Glaser, 
1981). The conformational change that follows the 
proteolytic cleavage results from the breakage of thiolester 
bond, which in turn results in the formation of covalent 
linkage between a2'^ and bound proteinase (Sottrup-Jensen and 
Hansen, 1982). Various observations listed below made at 
later dates support this hypothesis. (1) Inactive 
proteolytic enzyme or anhydrotrypsin (an inactive form of 
12 
trypsin) was not entrapped in a2M (Wu et al., 1981). <2) The 
conformational change occurring in a2Mi following entrapment 
was detected by electron microscopy (Bloth et al . , 1968), 
hydrodynamic studies (Gonias et al., 1982), X-ray scattering 
techniques (Brangegard et al., 1982). (3) "Slow" to "Fast" 
shift in electrophoretic mobility in non-denaturing PAGE 
(Barrett et al., 1979). I_n. vi vo clearance studies have been 
shown that half life of circulating a2M-proteinase complex 
is only 2-4 min. (Imber and Pizzo, 1981) which is strikingly 
low than that of native 02'^ • "^^^ drastic reduction in the 
circulating half life of a2'*'~P''°*^ ^ "^^^^ complex is 
attributable to the binding of complex by the specific 
receptors present on hepatocytes and cells of 
reticuloendothelial cells (Debanne et al., 1975; Imber and 
Pizzo, 1981). Another convincing evidence of tne trap 
hypothesis is the masking of antigenicity of the entrapped 
proteinase. a2M entrapped proteinases have been shown 
neither to induce antibodies nor interact with those 
preformed (Haverback et al., 1962). In case of large 
molecular weight proteinase like plasmin, antigenicity is 
not completely masked, presumably, due to the inability of 
a2M to completely mask its antigenic sites (Harpel and 
Mossenson, 1973). 
Smal l p r i m a r y amines such as m e t h y l a m i n e and e thy lam ine 
may r e a c t d i r e c t l y w i t h a2^ t h i o l e s t e r b o n d , i n the absence 
o f p r o t e i n a s e and r e n d e r i t i n a c t i v e ( B a r r e t t e t a l . , 1979; 
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Sottrup-Jensen et al., 1980). The reaction results in 
covalent incorporation of the amine in a2M (Swenson and 
Howard, 1779) with the liberation of free sulfhydryl groups 
<Salvesen et al., 1981) and conformational change in 
molecule similar to that observed in a2'^~P'r'oteinase complex. 
Amine transformed a2M is cleared by the cells of 
reticuloendothelial system in exactly in the same way as the 
proteinase treated a2'*' (Van Leuven et al., 1979; Imber and 
Pizzo, 1981). 
MODELS OF 02!! STRUCTURE : 
Various workers have proposed several models that are 
compatible with previous studies of the structure, function 
and phylogeny of a2M- Feldman et al. (1985) proposed that 
a2M is composed of four subunits and appear generally 
cylindrical and as Cyrillic "H" in electron micrographs. A 
plane perpendicular to the axis of the cylinder and crossing 
halfway between the ends of the molecule separates the 
inhibitor into two identical functional halves. Each half is 
made up of a ring with four arms (two per monomer) 
projecting from one side. Each monomer consists of one long 
arm called trap arm, and one short arm. The other side of 
the ring makes contact with second functional half (Fig.4a). 
The proteinase binding sites are on either side of the 
central ring. Once the bait region is cleaved, trapping of 
the proteinase can occur by the movement of one trap arm of 
each subunit. The thiolester within a pair are close 
Figure 4 Models of (X2M 
(a) Three dimensional structure of 0(2^  as 
proposed by Feldman et al . (1985) showing 
"slow" and "fast" forms. 
(b) Model of cx2^ proposed by Liu et al. (1987) 
showing native (X2^ and the two possible half 
molecules. 
4a 
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together (at base of adjacent trap arms) whereas two pairs 
are located 7 nm (diameter of the ring) apart. Cleavage of 
thiolester allows the trap arms to swing. In this model, 
reaction of amine with thiolester results in the same 
conformational change as obtained by proteolytic cleavage of 
the bait region. Moreover, because trap arms are only moving 
parts in this model, they postulated that receptor 
recognition site is located at the base of the trap arms. 
Exposure of this site would be affected by the change in 
conformation of the molecule as a whole and arm in 
particular. Since subunits are identical, each arm must have 
single receptor recognition site, that is exposed 
independently as was observed by Marynen et al. (1981) and 
Strickland et al. (1984). The "slow" to "fast" transforma-
tion of a2M not only require trap closure but also the 
realignment of juxtaposed chains of amino acid at the half 
molecule junction site, to decrease the apparent separation 
of the functional halves. 
Liu et al . (1987) proposed a model of <X2^ that has same 
symmetry as that of the Feldman's model, but the subunits 
are arranged in an antiparallel manner around the main axis 
rather than bilateral pattern as shown in Fig. 4b. The 
subunit is Z shaped structure with a short arm and a long 
arm corresponding to the arms of the whole molecule. They 
postulated that the enzyme binding sites are composed of 
parts of all four subunits and contribution from any two 
16 
pairs are sufficient to retain some binding properties, 
explaining the fact that the half molecule formed either by 
reduction of disulfide bonds or disruption of non-covalent 
interactions between half molecules are active. An 
additional feature of this model is that since the bound 
enzyme is in proximity of all four subunits of the protein, 
negative cooperativity is possible. They further proposed 
that trapping of proteinase requires the presence of all 
four subunits of «2'*'» though half molecules can bind 
covalently or non-covaiently to the proteinase molecule but 
they cannot trap, and prevent the proteinases from reaction 
with soybean trypsin inhibitor, as was observed. 
Delain et al. (1988) using immuno—e1ectron microscopy 
and employing a panel of monoclonal antibodies studied the 
3-dimenslonal organisation of human a2M- These workers 
proposed that a2M has rounded doughnut like shape with an 
excentered cavity which is in marked contrast with the 
Feldman model. The globular domain of native a2M unfolds 
after proteolytic cleavage, to build the lateral walls of 
the Cyrillic "H" structure of a2M (observed in electron 
microscopy), exposing the receptor binding domain located 
near the tip of the trap arms. 
PHYSIQLDGICflL ROLE OF 02!! = 
The cx2^ provides a potential for controlling the 
activity of proteinases by sterically shielding and rapid 
17 
clearance. It may function as back up inhibitor under 
conditions where primary inhibitors eventually become 
depleted e.g. in clotting and fibrinolysis (Sottrup-Jensen, 
1989). o<2M may also be involved in binding of proteinase 
dissociated from reversible proteinase-proteinase inhibitor 
complex. However, this proteinase inhibitory function of <X2^ 
is not believed to be of prime importance because for 
virtually every known endogenous mammalian proteinase, more 
specific and more rapidly acting antiproteinases have been 
identi fi ed. 
Alpha-2-macroglobulin does not prevent various diseases 
resulting from deficiency of these proteinase inhibitors (La 
Marre et al., 1991). It has not been demonstrated whether 
a2'^ limits the severity of the clinical signs in these 
deficiency states. Although the primary function of a2M is 
yet to be ascertained, it is clear that it plays some 
essential physiological role because complete absence of a2M 
has not yet been detected and is probably lethal. 
Previous studies have shown that a2M is a major binding 
protein for zinc, accounting for the binding of about ZO'A of 
total serum zinc (Parisi and Vallee, 1970; Prasad and 
Oberleas, 1970). More recent studies have implicated a2^ as 
a significant binder, carrier and clearance protein for 
physiologically important cytokines such as Tumor necrosis 
factor (Wollenberg et al., 1991), Transforming growth factor 
18 
(La Marre et al., 1991), Interleukin-lB (Earth and Luger, 
197B) and interleukin-6 (Matsuda et al., 1989). a2M may have 
carrier function in which cytokines circulate bound to 
native 02^ and/or clearance or targeting role for those 
cytokines that preferentially bind to activated a2M and are 
delivered specifically to cells with (X2^ receptors. 
Alpha-2-macroglobulin may play an important role in the 
development and functioning of cells of lymphoreticular 
system (Graham et al., 1975). While there is no direct 
evidence that 02M plays crucial role in immune response in 
vi vo, a number of observations suggest that the possible 
immunological significance of this protein cannot be ignored 
(James, 1980). There are reports that 012^ is synthesised and 
secreted by human monocyte and adherent lung cells (Hovi et 
al., 1977). a2M may also stimulate the development of 
lymphocytes and granulocytes playing important role, in 
leukopoiesis and erythropoiesis (Sontag et al., 1971). 
Additional evidence suggest that (X2^ might influence the 
differentiation of lymphoreticular cells (Graham et al., 
1975). 02M can also modulate immune response by inhibiting 
other immunologically important events known to have an 
active serine esterase requirement (for e.g. generation and 
release of mediators of inflamation, phagocytosis) (James, 
1980). Thus, initial binding of proteinase by a2M would 
inhibit proteinase dependent reaction and the a2M~proteinase 
complex could transport number of cytokines and growth 
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factors while subsequent endocytosis of the complex might in 
turn regulate proteinase secretion (James, 1980; Johnson et 
al., 1982). 
STUDIES ON CHEMICAL MODIFICATION OF 02?! : 
Studies have been conducted over the last decade on 
chemical modification of a2M by crosslinking and other group 
specific reagents. These studies can yield information on 
oligomeric state of protein, distribution of certain amino 
acids near the inter-subunit contact surface (Swamy and 
Surolia, 1988) and also the symmetry of the oligomer (Pillai 
and Bachhawat, 1979). The most commonly used crosslinking 
reagents in protein chemistry are a,w dialdehydes, 
especially glutaraldehyde. Crosslinking of protein has been 
used for protein stabilization and prevention of unfolding 
of tertiary structure (Sheehan et al . , 1990) in denaturing 
condition. Even though glutaraldehyde is most commonly used 
crosslinking reagent, chemistry of its interaction with 
protein is not entirely clear. Nuclear magnetic resonance 
studies clearly demonstrate that glutaraldehyde does not 
exist as 5-carbon a-w dialdehyde alone but largely as 
polymeric a,Q unsaturated dialdehyde resulting from 
condensation of several molecules of 5-carbon glutaraldehyde 
(Richards and Knowles, 1968). It is this polymeric nature of 
the glutaraldehyde that makes it an excellent crosslinking 
agent. It can react and crosslink amino groups that are 
sterically far off. Glutaraldehyde was found to react 
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primarily with N-terminal amino group of protein, amino 
group of lysine and a-amino groups of amino acids (Habeeb 
and Hiramoto, 1968). The sulfhydryl groups of cystiene and 
imadazole groups were also found to be partially reactive. 
Barrett et al. (1979) crosslinked 02^ with glutaral-
dehyde and reported the formation of crosslinked (X2^ 
tetramer and crosslinked half molecules, both lacking 
activity and "slow" to "fast" transformation. They 
speculated that since crosslinking of fast form of a2M by 
g lutaraldehyde formed only <X2^ tetramer, conformational 
change occurring after trypsinization leads to the 
compaction of the subunits. 
Studies of Gonias et al. (1981a) on a^^ crosslinking by 
cis-dichlorodiamine platinum II-(cis-DDP II), have shown 
that when (X2^ ^'^^ a2M~iiethyl amine complex was reacted with 
cis-DDP, it results in protein crosslinking and loss, of 
receptor binding. However, when cis-DDP is reacted with (X2^ 
"slow" form, it locks the 0(2^ in the native "slow" state. 
Addition of trypsin to cis-DDP treated a2M resulted in bait 
region cleavage without thiolester bond cleavage, proteinase 
binding, receptor recognition site exposure or a change in 
electrophoretic mobility in non denaturing PAGE. 
Van Leuven et al. (1982) isolated an anomalous complex 
of 0(2^ after chemical modification by cyanylation with 2,4-
dinitropheny1thiocyanate during methylamine reaction. The 
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complex moved as the electrophoretically slow form even 
though its thiolester bonds reacted with methylamine. 
Similar anomalous complex of <X2M was isolated by Van Leuven 
et al. (1982), when a2^ was trypsinized during functional 
modification by methylamine. The trypsin, though bound or 
entrapped in such anomalous complex was still reactive 
towards soluble soybean trypsin inhibitor and was capable 
of acting on high molecular weight substrate e.g. 
haemoglobin. The inhibition of trypsin entrapped in such 
anomalous complex of 0(2^ with STI was, however, less as 
compared with reaction of free trypsin with STI. However, 
trypsin of such "Trypsin-inhib i tor-inh ibi ted" a2li-trypsin 
complex did not bind to immobilized STI owing to steric 
factor, as they postulated. 
AIM OF THE PRESENT STUDY : 
As has been mentioned previously, studies on chemical 
modification and crosslinking have led to the isolation and 
characterisation of anomalous complexes of (X2M. The 
trypsinized a2M-cis-DDP complex behaves as 
e1ectrophoretically slow form. Similarly, methylamine 
incorporated cyanylated 02^1 moves as slow form of a2M» even 
though it has thiolester cleaved. Another anomalous complex 
of (X2^ was isolated when a2M was trypsinized during 
methylation reaction. The entrapped trypsin of such 
anomalous complex could be inhibited by soluble STI and was 
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capable of cleaving large molecular weight substrates such 
as haemoglobin. 
In continuation with chemical modification studies on 
a2Mi we have chemically modi fi ed/crossl inked native (X2^ with 
glutaraldehyde under controlled conditions and isolated a 
modified form of (X2^ which moves almost like the "fast" form 
in non-denaturing PAGE, yet retains most of the properties 
intrinsic to "slow" form of o(2M. Some properties of the 
glutaraldehyde modified, electrophoretically "fast" yet 
native 0(2^, have been investigated. 
EXPERIMENTAL 
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MATERIALS 
Chemicals used in the studies were obtained from the 
source indicated against their names. Glass distilled water 
was used in all the experiments. 
Chemical Source 
Acetic acid Qualigens, India. 
Acetonitrile Qualigens, India. 
Acrylamide Sisco Res. Lab., India, 
Ammonium persulfate Sisco Res. Lab., India. 
Ammonium sulfate Sisco Res. Lab., India. 
Benzoylarginine-p-nitroani1ide Sigma Chem. Co., USA 
Bovine serum albumin Sisco Res. Lab., India. 
Bromophenol blue B.D.H. Poole, England. 
Coomassie brilliant blue R-250 Sisco Res. Lab., India. 
Copper sulfate B.D.H., India. 
Cyanogen bromide Sisco Res. Lab., India. 
Diethylaminoethy1 cellulose Sisco Res. Lab., India, 
Di-sodium hydrogen phosphate E.Merck, India. 
Ethanolamine B.D.H., India, 
Folin Ciocalteu's phenol reagent Loba Chemie., India, 
Glutaraldehyde E.M. Sciences, U.S.A. 
Glycerol Qualigens, India. 
Glycine Sisco Res. Lab., India. 
Hydrochloric acid E.Merck., India. 
Isopropanol Qualigens, India, 
Methanol E.Merck., India. 
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2-mercaptoethanol 
N,N'-methylenebisacrylamide 
N,N,N'N'-tetramethylenediamine 
Bephadex G-200 
Sepharose-4B 
Sodium dihydrogen phosphate 
Sodium dodecyl sulfate 
Sodium hydroxide 
Sodium potassium tartarate 
Sodium tetraborate 
Soybean trypsin inhibitor 
Sucrose 
TrinitrobenzoyIsulfonic acid 
Tris(Hydroxymethyl)aminomethane 
Trypsin 
Merck-Scherchardt, Germany. 
Sisco Res. Lab., India. 
Koch-light Lab. Ltd., 
England. 
Pharmacia Fine Chem., 
Sweden. 
Sisco Res. Lab., India. 
E.Merck., India. 
Sigma Chem. Co., U.S.A. 
E.Merck., India. 
E.Merck., India. 
E.Merck., India. 
Sigma Chem. Co., U.S.A. 
Sisco Res. Lab., India. 
Sigma Chem. Co., U.S.A. 
Sigma Chem. Co., U.S.A. 
Sisco Res. Lab., India. 
Blood :- Freshly outdated human blood was obtained from J.N. 
Medical College Hospital. Samples of blood were centrifuged 
and plasma collected by aspiration. 
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METHODS 
I. PURIFICATION OF ALPHA-2-riACRDGLDBULIN : 
a) Ammonium Sulfate Fractionation :- 200 ml of outdated 
human plasma was taken and 22.8 gms of solid ammonium 
sulfate (20*/. saturation) was added with gentle stirring 
at 4°C. After 10-12 hrs, the precipitate was removed by 
centrifugation at 5,000 rpm for 15 min. To 195 ml of 
remaining supernatant was added 24.6 gms of ammonium 
sulfate to give final saturation of 407.. The solution 
was allowed to stand at 4*'C for 12-16 hrs. The 
precipitate was recovered by centrifugation at 15,000 
rpm for 20 min and dissolved in distilled water. The 
dissolved precipitate was extensively dialysed against 
several changes of 0.01 M sodium phosphate buffer pH 
8.0 in cold. 
b) Ion Exchange Chromatography :- DEAE cellulose was used 
for the isolation of a2 macroglobulin. The resin was 
kept in distilled water and when it has almost 
completely settled, fines were removed by decantation. 
This step was repeated four-five times. For 
regeneration, the ion-exchanger was suspended in 0.5 N 
HCl for half an hour. It was washed in Buchner funnel 
, until the pH of the filtrate was around 7.0. It was 
then kept in 0.5 N sodium hydroxide for same period of 
time and again washed with water until the pH was 
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around neutral. The DEAE-cellulose was resuspended in 
the operating buffer to get a homogenous slurry. The 
slurry was then poured into clean vertically mounted 
glass column. The column was gradually packed and final 
flow rate of 35 ml/hour was slowly adjusted. The column 
was washed with 5 bed volumes of operating sodium 
phosphate buffer pH 8.0. Protein samples were applied 
on column surface after buffer was carefully removed 
from its surface. The column was washed with 2-3 bed 
volumes of the buffer. Elution was performed with 
linear gradient (0-0.4 M) of NaCl in 0.01 M sodium 
phosphate pH 8.0. 5.0 ml fractions were collected and 
assayed for protein and a2 M. 
c) Sephadex Gel Fi1tration Chromatography :- Sephadex G-
200 column was prepared as recommended by Peterson and 
Sober (1962). The gel was allowed to swell in 
sufficient amount of distilled water for 5 hrs in 
boiling water bath. After swelling the gel, fines were 
removed by suspending the gel in two to four fold 
excess eluent solution and allowing 90 to 95*/. of the 
gel to settle down. The remaining gel in supernatant 
solution was rapidly removed by suction. A clean glass 
column was mounted on sturdy vertical support. One half 
bed volume of eluent was added to the mounted column in 
order to check for leaks and to flush air bubbles from 
the dead space. The slurry was then poured gently down 
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a glass rod into the column with care to avoid 
generating air bubbles. The freshly poured gel was 
allowed to settle for 10 to 15 min, keeping the column 
outlet closed. After the outlet was subsequently 
opened, the flow rate was gradually increased. After 
accomplishing a constant flow rate that was higher than 
that required for final elution, the column was 
adjusted to the required flow rate. The packed column 
was then washed with 2 bed volumes of operating buffer 
(0.1 M sodium phosphate containing 0.1 M KCl pH B.O). 
In order to check the uniform packing of column, as 
well as to determine the void volume, V Q , of the column 
a band of 2*/. (w/v) of blue dextran was passed through 
the column. The volume of blue dextran and protein 
applied on column should not exceed 5 percent of the 
total bed volume of the column. 
II. IWflDBILIZATION OF TRYPSIN AND SOYBEAN TRYPSIN INHIBITOR; 
Activation of Sepharose 4B was done as described by 
Porath et al. (1965). 10.0 gm of Sepharose was washed 
thoroughly with distilled water in a Blichner funnel. The gel 
was dried and suspended in 10.0 ml of 2.0 li Na2C03 and 
thoroughly mixed. 2.0 ml acetonitrile containing 2.0 gm 
cyanogen bromide was added to the beaker containing 
Sepharose and the contents mixed thoroughly in cold for 10 
min. After the required time, the gel was immediately washed 
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successively with 0.1 M bicarbonate buffer pH 8.5, distilled 
water and once again with buffer. After thorough washing, 
the activated Sepharose was dried and resuspended in 10.0 ml 
of 0.1 M bicarbonate buffer pH 8.6. 10.0 mg of trypsin/STI 
dissolved in same buffer was stirred with activated 
Sepharose for 24 hrs in cold. The immobilized trypsin/STI 
was separated from free trypsin/STI by centrifugation and 
protein in supernatant was quantitated in order to calculate 
the amount of protein immobilized. The matrix was thoroughly 
washed with 0.1 M sodium bicarbonate buffer pH 8.5 
containing 1.0 M sodium chloride to remove non-covalently 
bound trypsin/STI from the matrix. 20.0 ml of this washed 
matrix with 0.2 ml of 98*/. ethanolamine for 2 hrs at 4'C. The 
immobilized trypsin/STI was successively washed with 0.1 N 
sodium bicarbonate pH 8.5 containing 1.0 M sodium chloride, 
distilled water and once again with buffer. 
III. CRD55LINKING OF ALPHfl-2-WACRDBLOBULIN : 
Alpha-2-macroglobulin was crosslinked with glutaral-
dehyde by the method of Barrett et al. (1979) with slight 
modif ication. 
A dilute solution of a2M (0.5 mg/ml) was treated with 
10.0 mM glutaraldehyde for 30 min at lO'C in sodium 
phosphate buffer pH 8.0. The reaction was stopped by 
incubating with 200 mM glycine for same period of time. The 
solution so obtained was applied on a Sephadex G-200 column 
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and. the -firBt peak eluting after the void volume was 
collected and pooled. 
IV. POLYACRYLftMIDE GEL ELECTR0PHORE5I5 : 
PAGE was performed by the Tris-Glycine system of 
Laemmli (1970) using slab apparatus manufactured by 
Biotech, India. 
Routinely a 5*/. acrylamide gel was used although in few 
experiments 3-7.5'/. gradient gel was also used. Stock 
solution of 30*/ acrylamide containing 0.8'/. bisacryl amide. 
1.0 M Tris (pH 6.8 and 8.8) and 10'/. SDS were prepared and 
mixed in appropriate amounts to give the required final 
concentration. It was then poured into the mould formed by 
two glass plate (10x10 cm) separated by 1.5 mm spacer. A 
comb providing a template for 7 wells was inserted into the 
gel before the polymerization began. When the polymerization 
was complete in about an hour, the comb was carefully 
removed and wells were overlaid with running buffer. Protein 
samples were prepared to give final concentration of 0.0625 
M Tris HCl pH 6.8 and 10*/. (v/v) glycerol and trace of 
bromophenol blue as a tracking dye. In SDS samples, 
additional 1'/. (w/v) SDS and 2'/. (v/v) fl-mercaptoethanol was 
added and they were incubated at 37"C for 45 min. 
Electrophoresis was performed in electrode buffer containing 
0.025 M Tris, 0.2 M glycine, at 100 V till the tracking dye 
reached the bottom of the gel. Protein bands were detected 
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by staining the gels with 0.1'/. coomassie brilliant blue R-
250 in 40*/. isopropanol and 10*/. acetic acid. Destaining was 
carried out with 10'/. glacial acetic acid. 
V. PROTEIN ESTIMATION : 
The procedure described by Lowry et al. (1951) was 
followed. Different volumes of protein solution were taken 
in a set of tubes and final volume was made upto 1 ml with 
buffer. To this was added 5 ml of alkaline copper reagent 
containing one part of 0.5*/. (w/v) copper sulphate in 1'/. 
sodium potassium tartarate and 50 parts of 2'/. (w/v) sodium 
carbonate in 0.1 N sodium hydroxide. After 10 min incubation 
at room temperature^ 0.5 ml of 1.0 N Folin's Phenol reagent 
(prepared according to the method of Folin and Ciocalteu, 
1929) was added and tubes were instantly vortexed. The color 
so developed was read at 660 nm after 30 min against blank 
which was prepared in similar manner except for the absence 
of protein. 
Protein in the column fractions were monitered at 280 
nm in D Q - 4 0 Spectrophotometer. 
VI. ESTIMATION OF AMINO GROUPS : 
Free amino groups were determined by the method of 
Habib et al. (1966) with slight modifications. Glycine was 
used as an standard. Suitable aliquots of the protein 
samples were dissolved in 1.0 ml of O.l M sodium tetraborate 
buffer pH 9.3. Twenty five microlitre of aqueous 0.03 M 
TrinitrobenzoyIsulfonic acid, TNBS, was added and agigated 
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instantly to ensure complete mixing, and allowed to stand 
for 30 min. at 25°C. Absorbance of yellow color was read at 
420 nm against the reagent blank. 
VII. ASSAY OF ALPHA-2-MACRDGLOBULIN : 
(X2^ activity was measured as fraction of Trypsin 
Protein Esterase (TPE) activity retained in the presence of 
soybean trypsin inhibitor (STI). Suitable aliquots of 
inhibitor was diluted in 1.0 ml of 10 mM sodium phosphate 
buffer, pH 8.0. To this was added, 100 ^1 dOO iig) of 
freshly prepared trypsin (prepared in same buffer) and 
incubated at ZVC for 15 min. 100 \il (100 )ig) of STI 
(prepared in same buffer) was added and again left for 15 
min. at S y C after which a further volume of 0.8 ml buffer 
and 2 ml of freshly prepared BAPNA soln. (prepared by 
dissolving 43.5 mg BAPNA in 1.0 ml DMSO and the volume made 
upto 100 ml with buffer) was added and incubated again for 
30 min, at same temperature. A blank without trypsin but 
otherwise identical was incubated simultaneously. After the 
incubation time, reaction was stopped with 0.5 ml of 30'/. 
acetic acid and yellow colored p—nitroani 1 ide formed was 
read at 410 nm on Bausch and Lomb Spectronic 20 
Spectrophotometer. The a2M activity was me^ured as the 
product formed by the entrapped enzym«. It was calculated 
using molar extinction coefficient of 8800 M cm for p-
nitroanilide at 410 nm. The procedure followed was 
essentially that of Ganrot (1966). 
RESULTS 
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PURIFICATION OF 02 MflCROGLDBULIN : 
The purification procedure used in the present study 
was based on that reported by Miyata et al. (1981) with 
slight modification. Human serum proteins precipitated 
between 20% to 40*/. ammonium sulfate saturation were 
dissolved in distilled water and dialysed against several 
changes of 0.01 M sodium phosphate buffer pH 8.0 in cold. 
The preparation was subsequently bound and chromatographed 
on DEAE cellulose column. The bound proteins were eluted 
with a linear NaCl gradient of 0.0-0.4 M NaCl . 0(2^ eluted as 
second peak followed by other protiens which exhibited no 
trypsin inhibitory activity (Fig. 5 ) . The pooled DEAE 
fractions were chromatographed on G-200 column and a2M 
eluted just at the void volume as a single peak (Fig. 6). As 
shown in Table I, the ammonium sulfate fractionation 
resulted in a two fold increase in specific activity with 
80*/. yield. The DEAE cellulose fractionation improved the 
purification to 31-fold with a yield of 71*/., while Sephadex 
G-200 fractionation gave <X2^ preparation that exhibited 52 
fold higher specific activity than plasma with an yield of 
26*/.. 
Homogeneity of 0(2^ was determined by PAGE performed 
both in absence of SDS and reducing denaturing conditions. 
The purified preparation gave single major band in both SDS 
and non-SDS PAGE, corresponding to ex2^ (Fig. 7 & 8 ) . 
Figure 5 DEAE Cellulose Chromatography of a2M 
The ammonium sulfate precipitate obtained from 
100 ml of plasma were dissolved in 30 ml of 
distilled water and dialysed against several 
changes of 0.01 M sodium phosphate buffer pH 8.0 
in cold. The protein was applied on DEAE cellulose 
column (2.5x30 cm) and thoroughly washed. <X2^ was 
eluted with linear gradient of 0.0-0.4 M NaCl in 
0.01 M sodium phosphate buffer, pH 8.0. Elution 
was performed at a flow rate of 35 ml/hr and 5.0 
ml fraction were collected. The fraction were 
screened for a2'^  ^ ^^ivity and protein. 
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Figure 6 Sephadex 6-200 Gel Filtration 
The fraction containing (X2^ activity collected 
from DEAE column were pooled, concentrated, 
dialysed against 0.1 M sodium phosphate buffer 
containing 0.1 M KCl in cold. 5.0 ml of the 
dialysed sample was then loaded on Sephadex G-
200 column (2.5x82 cm) which was eluted at the 
rate of 25 ml/hr. Fractions of 5.0 ml were 
collected and assayed for 0(2^  and protein 
concentration. 
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Figure 7 Polyaci'ylamide Gel Electrophort-sis 
The electrophoretic pattern of different stages of 
purification of a2M in 5'/. non-denaturing gels are 
shown, 20 pg of each preparation was electropho-
resed on the minislab gel at room temperature at 
50 V. 
Lane A - P1asma 
Lane B - 20'/. to 40*/, ammonium sulfate fractions 
Lane C - DEAE cellulose fraction 
Lan^ D - Sephadex G-200 fraction 
A B C D 
Figure 8 5DS Pnly?.cryJ arr? dr G P I E> er^r nphrrr ;n j ?. 
Thp plectrophoretic pattern of d j f f ••-•-ei i: .-Ip.rxe^ of 
purification of 0(2^ ^n 7 = 5*/. f^ DS gels is -hcj«^ "i. 
15 pg of each preparation was elecvrop'''orpsed CKI 
the mini slab gel at room tempsr;-^ire iising 50 V, 
Lane A - Plasma 
L?ne D - 20'/.-40*/. ammi-nium fu] f-^  • .' fv.^ '-: ^ . r^  
Lane C - DEAE cellulose fraction 
Lane D - Sephiadex G~200 iracti'-n 
II 
A B C D 
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TABLE-I: P u r i f i c a t i o n of a^n from Outdated Human Blood 
Isolation Step Total Vol. Total activity Total Protein Sp. activity Yield Puri-fication 
(ol) (Units) (og) (Units/og) {%) (Fold) 
Plasma 100 736 6300 0.1 100 
20X to 40X Aiunoniuin 
sulfate precipitate 
DEAE cellulose 
Sephadex G-200 
30 
16 
35 
589 
523 
195 
2908 
168 
38 
0.2 
3.1 
5.2 
80.5 
71 
26 
2 
31 
52 
One u n i t i s p mole of p - n i t r o a n i 1 i d e formed p e r 30 min 
De te rmined by t h e method of Lowry e t a l . ( 1 9 5 1 ) . 
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PREPARATION AMD I SPLAT IC?] OF CROSSLIJSJKED ALP}-!A-2-
MACROGLOBULIN : 
The approach of Barrett et al. (1979) was employed for 
the crosslinking of 0(2^  with glutaraldehyde. To a 20 ml 
aliquot of 0.5 mg/ml a2M was added glutaraldehyde to a final 
concentration of 10 mM and the sample incubated for 30 min 
at lO'C. The reaction was terminated by the addition of 200 
mM glycine. The crosslinked material was subsequently passed 
through a column of Sephadex 6-200. Figure 9 shows the 
elution profile of the crosslinked a2M, which consisted of a 
major protein peak eluting at the void volume and a minor 
peak with an elution volume of 60 ml. The two protein peaks 
were pooled seperately. Only the first protein peak 
corresponding to o<2M tetramer in electrophoretic mobility 
showed trypsin inhibitory activity. 
The material in peak I migrated as a single band of 
slightly faster mobility than the native «2^ i" PAGE. SDS-
PAGE of the preparation in presence of 6-mercaptoethanol 
also gave a single band corresponding to tetramenc form of 
a2M (Fig. 10 & 11). 
EFFECT OF TRYPSIN TREATMENT : 
In order to investigate whether crosslinked a2M retains 
biological activity after crosslinking, the effect of 
trypsin on the electrophoretic mobility of native and 
crosslinked 0(2^  preparation were investigated. 
Figure 9 Purification of.Crosslinked a2M on Sephadex G-ZOO 
a2M preparation <0.5 mg/ml> was treated with 10.0 
mM glutaraldehyde for 30 min at lO'C. The reaction 
was terminated by the addition of 200 mli glycine. 
10.0 ml of the sample was loaded on Sephadex G-200 
column (1.2x80 cm) and the column was eluted at 
the rate of 25 ml/hr. Fraction of 5.0 ml were 
collected and assayed for a2M and protein 
concentration. 
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F i g t i r f ; 10 P o l y a c r y l c ^ t T i i d e iSe I L i n c t r a p h a r e s i e o f C i . t j s s l i n k e d 
The e l p r t r o p h o r e t i c pa'"-Herns o f d i f - f e r e n t 
p r e p a ' . ' a t i j n o f (^2^ ^ • •-'''' n o n - d e n a t u r i n g g e l s i s 
= h o w n . The p r e p s - r d t i o n uiprc e 1 s;ct r o p h o r e s e d or. t h e 
m i n i rJ. r b g c i a t room t e m p c - r a t i i r e . u s i n g 50 V . 
Lane A - N a t i v r <^-2^ 
Lane D - P l u t . ^ ! a l d e h y d e c r o s s l i n k t d c;2^' 
Lane C - n a j o r p r c t e i n p^ak o f Sephad^^x (3-200 
c o l u m n . 
JUU\ 
K- I 
A B C 
F i g u r e 11 CDH P n l y a r r y l a r r i d c G P ] E ) r - f r o p h a r e s i s o f Cross— 
l i n k e d o;2H 
The e 1 ec t r o p h o r e t ir. p n i V e r n of d i f f e r F n t 
p r e p a r a t i o n of 0(2'^ i'"' 3 - 7 . D 7 . g e l i s s h o w n . The 
p r e p a r a t i o n u.<pyp e 1 c r . t r n p h o r e r - e d on t h p m i n i s l a b 
Q6.1 a t T cjnm t e r n o e r a t u r e unir^g L'O V. 
Lane A - N ^ ' t i v e c ^ ^ u n d e r t e H o r i n q c o n H i t i o n r 
Lane B - N a t i v e C'p'l uridt?r n'-rt r e d u c i n g c o n d i t i o n s 
Lane C - Gl u t a r a I d e i i y d e CTciiisl i f iked a2f'' 
Lane D - 0.2^ p r c t r e a t e d w i t h t r y p s i n r n d c i c s s -
lir .kfcd I'.'i t h tj l u t a i a l d e h y d e ( u n d e r r e d n c -
i n g CO: :d i t i o n ) . 
B D 
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Trypsini zat ion transformed the native c<2M to the fast farm 
as reported earlier (Barrett et al., 1979). The mobility of 
crosslinked a^^ preparation was comparable with that of the 
"fast" form even prior to trypsin treatment and it was 
increased further as a result of exposure to trypsin 
(Fig. 12). 
ACTIVITY OF TRYPSIN ENTRAPPED IN a^fl = 
0(2^  entrapped trypsin activity was measured using both 
soluble and immobilized soybean trypsin inhibitor (STI). The 
data in Table 2 shows that activity of entrapped trypsin in 
native a2^ remains unaffected by the type of STI used. 
However, the activity of trypsin entrapped in crosslinked 
<X2^ was only about 307. of native 0(2^ 1 in presence of excess 
STI, but increased to 607. when the assay was performed in 
presence of immobilized STI. 
AMINO GROUP ESTIMATION OF or^ M : 
Amino groups in native and crosslinked 02^^ were 
determined in order to monitor the extent of reaction of (X2^ 
with glutaraldehyde and proteolysis. For this purpose 
crosslinked a2'^ ^ ^^ incubated with 4 fold molar excess of 
trypsin at 37°C for 10 min. The reaction was stopped by the 
addition of 1 mN PMSF. Treatment of (X2^ with insoluble 
trypsin was carried out at 37''C for 3 hrs with constant 
shaking. The sample were centnfuged to remove immobilized 
trypsin. Controls in which soluble trypsin was inactivated 
Figure 12 E^fp^t of Trysjsin on Nativr* and Cross! inked a2 
Macroglobul i«-i 
The figure hows the PAGE of nat•ve and 
crosslinkea °^2^' The purified native and 
crosslinkea a2''^  i^a.^ treated with 2 fold molar 
excess of trypsin fL>r 1L" min -^t ,^7°r. The reaction 
was stopped by the <ic!'J3l:on of 1 mh PMSF. The 
samples were then fcipcii ch'inps.'c! on b^ . gel. ''he 
procedure of Laemmli (1970) was -inl lowed. 
Lane A - Native 02^ 
Lane B - Native 02^ treated with trypsin 
Lane C - Glutaraldehyde crossiinked a2^' 
Lane D - Glutaraldehyde crossiinked cx2^ treated 
with trypsin 
A B C D 
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TABLE-II: Effect of STI On Alpha-2-Macro9lobulin Entrapped 
Trypsin 
a2M Activity Activity Retained 
Preparation (Units/mg ) ('/. ) 
Native <X2M Entrapped + Soluble STI 125 100 
Native a2M Entrapped + Immobilized STI 125 100 
CrosBlinked a2^ Entrapped + Soluble STI 37 30 
Crosslinked a2'*' Entrapped + Immobilized STI 75 60 
Trypsin + Soluble STI 0.0 0.0 
Trypsin + Immobilized STI 0.0 0.0 
•)(. 
Unit is pM p-nitroani1ide formed per 30 min per mg protein. 
Values are mean of three independent experiments done in 
triplicate. 
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with PMSF prior to incubation with «2M» was simultaneously 
run to determine amino groups of the enzyme. Table III 
clearly shows significant decrease in amino groups in a2M as 
a result of crossl ink ing. There was about 17*/ modification 
of amino groups when (X2^ was treated with glutaraldehyde. 
Amino groups of native and crosslinked a2M were also 
estimated after trypsinization under conditions described 
above. An increase of amino groups in trypsinized native and 
crosslinked preparation was observed as a result of exposure 
to trypsin indicating peptide cleavage. The number of amino 
groups of soluble trypsin treated crosslinked preparation 
were lower than those of the uncrosslinked trypsinized 
preparation. Similar effects but of lower magnitude were 
obtained with immobilized trypsin. The data thus suggest 
that immobilized trypsin causes lower degree of cleavage in 
native as well as crosslinked preparation as compared to 
soluble trypsin. Also, the proteolysis of the crosslinked a2'*' 
preparation was lower than native a2M both when treated with 
soluble or immobilized trypsin. 
KINETICS DF NATIVE AND CROSSLINKED ogd. ENTRAPPED TRYPSIN : 
Affinity of trypsin towards BAPNA was measured and a 
typical Michealis-Menten curve was observed. The double 
-2 
reciprocal plot shows that Km of soluble trypsin is 50x10 
M. The Km obtained for trypsin entrapped in native a2M is 
slightly increased to 90x10""^ M (Fig. 13, 14 & 15). 
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TABLE-III: Effect of Glutaraldehyde and Trypsin Treatment on 
The Amino Groups of Alpha-2-macroglobulin. 
Native Crosslinked 
Treatment (ji moles of NH2/mg protein ) 
None 197 164 
Soluble trypsin treated 287 219 
Immobilized trypsin treated 229 180 
Values are mean of three independent experiment done in 
triplicate. 
Figure 13 Effect of Substrate Concentration 
To a series of tubes containing 20 pg of trypsin 
was added increasing amount of BAPNA in 10.0 mM 
phosphate buffer pH 8.0 and total volume was made 
3.0 ml. The tubes were incubated for 1 hr at Z7'C 
and the color was read at 410 nm. 
o.i5r 
.03 .04 
l / [ S ] ( m M ) 
Figure 14 Effect of Substrate Concentration on Entrapped 
Trypsin 
To a series of tubes containing 550 pg of native 
<X2^ was added 100 pg of trypsin and incubated for 
15 min at 37'C. Free trypsin activity was 
inhibited by the addition of STI. To this was 
added increasing amount of BAPNA in 10 mM 
phosphate buffer pH 8.0 and total volume was made 
3.0 ml. The tubes were incubated for 1 hr at 37°C, 
and color formed was read at 410 nm. 
0.15 r 
02 .03 
l / [ S ] ( m M ) 
.04 .05 
Figure 15 Effect of Substrate Concentration on Entrapped 
Trypsin 
To a series of tubes containing 800 ^g of 
crosslinked a^^ was added 100 pg of trypsin and 
incubated for 15 min at Zl'Z. Unentrapped trypsin 
was inhibited by the addition of insoluble STI for 
same period of time at 37*C with constant shaking. 
To this was added increasing amount of BAPNA in 10 
mM phosphate buffer pH 8.0 and total volume was 
made to 3.0 ml. The tubes were incubated for 1 hr 
at 37"C, centnfuged and color of supernatant was 
read at 410 nm. 
10 n 
l/C S ] X10~^(mM) 
DISCUSSION 
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Interest in the unusual mechanism of inhibition of 
proteolysis by 0(2^ has led to the development of several 
strategies for its purification from mammalian sera. These 
include procedures based on the affinity of a2M for zinc 
(Kurecki et al., 1979), Snowdrop bulb lectin (Shibuya et 
al., 1988), and Cibacron Blue Sepharose (Virca et al., 
1978). However, for obtaining reasonably large quantities of 
(X2^i the procedure used by Miyata et al . (1931) that 
employs ion exchange chromatography and gel filtration was 
adapted with some modification. The modifications included 
the introduction of ammonium sulfate precipitation as the 
first fractionation step and reversing of the order of ion 
exchange and gel filtration. Using the modified procedure, 
it was possible to purify o(2M from human sera to give a 
purified preparation (Fig. 7 & 8) that was 52-fold enriched 
in specific activity with an yield of 26'/ (Table I). 
Alpha-2-macroglobulin of higher animals is tetrameric 
(Hall and Roberts, 1978) although dimeric and even monomeric 
form have been characterised (Esnard and Ga thier, 1980). 
The four identical subunits of mammalian a2M are organised 
as dimer of dimers, with two disulfides linked dimers 
interacting non-covalently (Harpel, 1973; Hall and Roberts, 
1978). Half molecule of tetrameric a2'^ ^ ^^ ^ been formed by 
disruption of non-covalent forces (Liu et al., 1987) as well 
as by breaking disulfide bond (Gonias and Pizzo, 1983) and 
both forms were claimed to retain significant biological 
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acti vi ty. 
A biologically active tetrameric a2M with all the four 
subunits joined covalently has not been described so far. In 
an earlier study, crossl ink ing of native ot2M with 
glutaraldehyde resulted in the production of covalently 
linked dimers and tetramers both lacking inhibitory activity 
(Barrett et al., 1979). Extensive but reversible 
crosslinking with cis-dichlorodiamine platinum-II (cis-DDP 
II) on the other hand did not abolish o(2M biological 
activity although it locked the molecule in the "slow" 
conformation (Roche et al., 1988). Treatment of the 
trypsinized cis-DDP treated <X2^ with the platinum chelator, 
diethyldithiocarbamate (DDC) liberated free sulfhydryls and 
transformed the molecule to the fast form (Roche et al., 
1988). The covalently linked tetrameric form obtained in the 
present study exhibited faster mobility on non-denaturing 
gels (Fig. 10) comparable to the "fast" form of a2M. 
Mobility of the preparation, however, increased further as a 
result of trypsinization (Fig. 12) and a significant amount 
of the proteinase became associated with the molecule (Table 
II). It is of interest to note that cis-DDP treated a2M 
migrates more slowly than the native molecule (Roche et al., 
1988) which the author believe is the result of small 
increase in the stokes radius of the molecules. One likely 
reason for the increase in mobility of the glutaraldehyde 
treated o(2M is the decrease in the positive charge on the 
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molecule due to modification of the lysine residues. 
Additional negative charge may be introduced in the molecule 
due to the reaction of residual aldehydic groups on 0:2^ with 
glycine. Us.e of ethanolamine to terminate the reaction 
resulted in the formation of a molecule with slightly lower 
mobility (unpublished data). In a recent study Mir et al. 
(1992) have shown that e1ectrophoretic mobility of BSA 
significantly increased as a result introduction of negative 
charge by succinylat ion. However, a decrease in stokes 
radius of the (X2^ caused by g lutaraldehyde treatment is one 
of the likely alternative. 
Migration of the g lutaraldehyde treated a2M at the 
position of the tetrameric ajM in SDS PAGE (Fig. 11) rules 
out the fragmentation of the molecule during crosslinking. 
One can also rule out the possibility of the glutaraldehyde 
treatment transforming the native a^^ to the "fast" form 
with cleaved thiolesters and altered conformation as the 
treatment of the crosslinked molecule with trypsin resulted 
in association of the proteinase with the inhibitor and 
concomitant further increase in its electrophoretic mobility 
in non-denaturing gels. 
The observation that trypsin associated with 
crosslinked a2M exhibited lower activity in the presence of 
soluble STI than when the inhibitor was Sepharose bound 
indicates incomplete trap closure. A comparable (X2^ 
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preparation that binds trypsin without protecting it from 
soluble STI and facilitates high proteotytic activity by the 
bound trypsin has already been described by Van Leuven et 
al. (1982). The a2M preparation was obtained by cyanylation 
of the sulfhydryls of native a2M during methylation reaction 
with the help of 2,4,dinitropheny1thiocyanate. As observed 
in the present studies (Table II), the cyanylated (x-2^ too 
exhibited markedly reduced inhibitory activity towards 
trypsin (Van Leuven et al . , 1982). 
Amino group quantitation was carried out to monitor the 
extent of reaction of the a2'*' with glutaraldehyde as well as 
peptide bond hydrolysis. About 17'/. of amino groups of <X2^ 
were modified by glutaraldehyde treatment but it is 
difficult to predict the exact number of crosslinks 
introduced in the molecule. Trypsinization of native and 
crosslinked 0(2^ led to the release of additional amino 
groups. As can be anticipated, the proteolysis was 
significantly lower when Sepharose bound trypsin with 
restricted accessibility due to its large dimension was used 
both with native and crosslinked a2M (Table III). The bait 
region of ot.2^ is the most likely site of attack by native or 
immobilized trypsin in view of its remarkable susceptibility 
and accessibility to various proteinases (Hall et al., 
1981). Modification of the amino groups of the bait region 
by glutaraldehyde could account for the low proteolysis 
observed with the crosslinked inhibitor in view of the 
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specific ability of trypsin to cleave peptide bonds whose 
carboxyl function are contributed by lysine and arginine. 
Studies on kinetic parameters of trypsin entrapped in 
native and crosslinked <X2^ has led to apparently 
contradictory results. STI inhibition studies suggest that 
crosslinked a2M entrapped trypsin is more exposed than that 
entrapped in native (X2^ but the Km of trypsin entrapped in 
crosslinked <X2^ was found to be slightly increased (Fig. 14 
& 15). The decrease in apparent affinity of trypsin in 
crosslinked a2M is therefore difficult to explain and it 
could be the result of change of charge in the vicinity of 
trypsin associated with crosslinked a2M-
SUMMARY 
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Alpha-2-macroglobulin is a major proteinase inhibitor 
present in blood plasma of vertebrates. It is unique in its 
action in that it does not directly block the active site of 
the proteinase, but physically entraps them following a 
proteolytic attack in an exposed stretch, the "bait region". 
The primary structure of each Mr ~ 180,000 subunit is 
identical and they are arranged to form two identical and 
adjacent proteinase binding sites. The tetramer is formed by 
the non-covalent association of the two disulphide bonded 
dimers. Many of the unusual characteristic features of <X2^ 
have been elucidated, but a consensus of the structure of 
the basic inhibitory unit has proven elusive. Active -half 
molecules have been reported by disruption of non-covalent 
forces as well as by breaking disulfide bonds and thus it is 
difficult to say whether the covalently linked dimers or the 
non-covalently linked dimers are biologically active. In the 
present study, a covalently crosslinked <X2^ was prepared and 
its properties investigated. 
Purification of human a2M was performed by ammonium 
sulfate fractionation, DEAE cellulose and Sephadex G-200 
chromatography. The preparation thus obtained, exhibited 52 
fold-increase in specific activity with an overall yield of 
26*/.. The crosslinked tetrameric a2M was prepared by 
treatment of a dilute solution of 0C2M (0.5 mg/ml > with 10 mM 
glutaraldehyde at pH 8.0 at lO'C for 30 min. The resulting 
crosslinked a^M tetramer was passed through a Sephadex G-200 
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column to remove the small amount of dimeric 02^ population 
obtained during the reaction. The a2M dimers completely 
lacked the trypsin inhibitory activity, while the 
crosslinked tetramer was capable of inhibiting trypsin. The 
trypsin inhibitory activity of the crosslinked tetramer was 
significantly lower than that of native o(2M. Trypsin 
associated with crosslinked <X2^ was more susceptible to 
inhibition by soluble soybean trypsin inhibitor than by the 
Sepharose bound soybean trypsin inhibitor. These studies 
suggest incomplete trap closure of the crosslinked a2M 
following cleavage of bait region and subsequent inhibition 
of the proteinase. The electrophoretic mobility of the 
crosslinked tetramer was faster than native (X2^ and was 
comparable to "fast" form of a2M. Trypsinyzed crosslinked 
o{2M tetramer showed still higher mobility in non-denaturing 
gel. The Km value of trypsin associated with crosslinked a2M 
was higher than that of trypsin entrapped in native a2M. 
However, the Km values of soluble trypsin and a2M entrapped 
trypsin were comparable. 
This study represents, to the best of our knowledge, 
the first successful attempt of obtaining a preparation of 
a2M with all the four subunits covalently crosslinked with 
retention of significant biological activity. 
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